Parkinson Disease Psychosis: Update

Parkinson Disease Psychosis: Update

Bibliographic Details
Main Author:	J. H. Friedman
Format:	Article
Language:	English
Published:	Hindawi Limited 2013-01-01
Series:	Behavioural Neurology
Online Access:	http://dx.doi.org/10.3233/BEN-129016

Similar Items

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
by: Combs BL, et al.
Published: (2017-03-01)

Parkinson’s disease psychosis
by: Jakel RJ, et al.
Published: (2014-03-01)

Quetiapine in the treatment of psychosis in Parkinson’s disease
by: Paul Shotbolt, et al.
Published: (2010-11-01)

Approach to the management of psychosis in Parkinson’s disease
by: Abhishek Lenka, et al.
Published: (2019-01-01)

Psychosis in Parkinson′s disease
Published: (2011-01-01)

The role of mirtazapine in the management of psychosis in Parkinson’s disease
by: N Uvais
Published: (2020-01-01)

Psychosis, apathy, depression and anxiety in Parkinson's disease
by: David A. Gallagher, et al.
Published: (2012-06-01)

Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
by: Carina R. Oehrn, et al.
Published: (2021-01-01)

Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
by: Khashayar Dashtipour, et al.
Published: (2021-01-01)

The experience of care partners of patients with Parkinson's disease psychosis.
by: Sneha Mantri, et al.
Published: (2021-01-01)

Evidence for the use of pimavanserin in the treatment of Parkinson’s disease psychosis
by: Harini Sarva, et al.
Published: (2016-11-01)

A clinical profile of patients with Parkinson′s disease and psychosis
by: B. R. Amar, et al.
Published: (2014-01-01)

Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis
by: Graham K. Murray, et al.
Published: (2017-04-01)

Psychosis in an elderly patient with parkinson′s disease: issues and considerations
by: Arghya Pal, et al.
Published: (2014-01-01)

First-episode psychosis: An update
by: Bonga Chiliza, et al.
Published: (2008-03-01)

Psychosis Assessment in Early-Stage Parkinson’s Disease: Comparing Parkinson’s Psychosis Questionnaire with the Brief Psychiatric Rating Scale in a Portuguese Sample
by: I. Cargaleiro, et al.
Published: (2012-01-01)

Psychosis in parkinsonism: an unorthodox approach
by: Onofrj M, et al.
Published: (2017-05-01)

Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
by: Joan Forns, et al.
Published: (2021-01-01)

Mirtazapine for the treatment of psychosis in Parkinson’s disease: Any silver linings?
by: Abhishek Lenka
Published: (2020-01-01)

Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis
by: Armstrong, M.J, et al.
Published: (2021)

The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson’s Disease
by: Nevena Divac, et al.
Published: (2016-01-01)

Kynurenine pathway in Parkinson's disease—An update
by: Dhivya Venkatesan, et al.
Published: (2020-12-01)

Parkinson’s Disease: Clinical Review and Update
by: Verónica Cabreira, et al.
Published: (2019-10-01)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
by: Paul Shotbolt, et al.
Published: (2009-05-01)

Management of Psychosis in Parkinson’s Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition
by: Raquel N. Taddei, et al.
Published: (2017-01-01)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
by: Zhang H, et al.
Published: (2019-07-01)

Update on the Management of Parkinson’s Disease for General Neurologists
by: Zvezdan Pirtošek, et al.
Published: (2020-01-01)

An update comment on the diagnosis and treatment of Parkinson's disease
by: Piu CHAN, et al.
Published: (2011-02-01)

Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis
by: Sneha Mantri, et al.
Published: (2021-02-01)

Methods of synthesis of Pimavanserin: the first drug approved for the treatment of Parkinson's disease psychosis (PDP)
by: Nader Robin Al Bujuq
Published: (2020-02-01)

Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease.
by: Osvaldo P Almeida, et al.
Published: (2016-01-01)

BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
by: Rodrigo R. Nieto, et al.
Published: (2021-06-01)

An update on best practice of deep brain stimulation in Parkinson’s disease
by: Christian J. Hartmann, et al.
Published: (2019-03-01)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
by: Chengqian Li, et al.
Published: (2020-12-01)

Neuroanatomical changes in Parkinson′s disease in relation to cognition: An update
by: K G Prakash, et al.
Published: (2016-01-01)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
by: Holly A Shill, et al.
Published: (2008-12-01)

Dancing and Parkinson’s disease: updates on this creative approach to therapy
by: Shanahan J, et al.
Published: (2017-09-01)

Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis
by: Lei Cui, et al.
Published: (2020-12-01)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
by: F. Wianny, et al.
Published: (2017-10-01)

Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report
by: Bruno Fukelmann Guedes, et al.